Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003

Characterization of the catalytic domain of poly(ADP-ribose) glycohydrolase

C. Patel, D. Koh, M. Jacobson, M. Oliveira

Med Sci Monit 2003; 9(1): 53-0 :: ID: 15116

Abstract

Poly(ADP-ribose) glycohydrolase (PARG) is an O-glycosidase, other members of this family of enzymes contain catalytic acidic residues surrounding the labile glycosidic bond. Previously an inhibitor-binding residue in bovine PARG (Y796) has been mapped to a region of highly conserved PARG sequences. We have targeted all conserved glutamic and aspartic acid residues in this region of PARG for site directed mutagenesis based on the hypothesis that PARG, like other O-glycosidases, will utilize a similar mechanism. The mutants were purified and catalytic activity as well as binding to a PARG inhibitor, ADP-HPD, was performed to show that the mutations did not interfere with the ability to detect a substrate like moiety. Our screen has revealed three essential residues, two vicinal glutamic acid residues found in the conserved sequence 755QEE757 and a third residue found in the conserved sequence 737VDFAN741. Identification of catalytic acidic residues along with recent identification of a polymer binding residue Y796 and a glycine rich region 745GGG747 allowed us to define a PARG ‘signature sequence’ [DFA-X4-GGg-X6–7-vQEEIRf-X3-YTGY] which we have used in conjunction with PHI-BLAST to identify distantly related PARG sequences. We found that the catalytic domain of PARG is predicted to contain a mostly beta sheet structure and a secondary structure pattern similar to that observed in the ADP-ribosyltransferase fold found in PARP-1 and bacterial toxin ADP-ribosyltransferases.

Keywords: Poly(ADP-ribose) glycohydrolase, PARG, ADP-ribosyltransferase fold

Add Comment 0 Comments

Editorial

01 May 2024 : Editorial  

Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)

Dinah V. Parums

DOI: 10.12659/MSM.944927

Med Sci Monit 2024; 30:e944927

In Press

14 Mar 2024 : Clinical Research  

Differential DHA and EPA Levels in Women with Preterm and Term Births: A Tertiary Hospital Study in Indonesia

Med Sci Monit In Press; DOI: 10.12659/MSM.943895  

0:00

15 Mar 2024 : Clinical Research  

Evaluation of an Optimized Workflow for the Radiofrequency Catheter Ablation of Paroxysmal Atrial Fibrillation

Med Sci Monit In Press; DOI: 10.12659/MSM.943526  

0:00

09 May 2024 : Review article  

A Review of the Current Status of Disease-Modifying Therapies and Prevention of Alzheimer’s Disease

Med Sci Monit In Press; DOI: 10.12659/MSM.945091  

09 Apr 2024 : Clinical Research  

Correlation between Thalamocortical Tract and Default Mode Network with Consciousness Levels in Hypoxic-Isc...

Med Sci Monit In Press; DOI: 10.12659/MSM.943802  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750